Keyword

rAAV2

Description: rAAV2 is a recombinant adeno-associated virus vector based on serotype 2, used to deliver genetic material in experimental and therapeutic studies.
OpenAlex ID: keywords/raav2
2003 · Hiroyuki Nakai, Eugenio Montini, et al. · Nature Genetics · 434
2001 · Sihong Song, Philip J. Laipis, et al. · Proceedings of the National Academy of Sciences · 121
2009 · George Aslanidi, Kenneth Lamb, et al. · Proceedings of the National Academy of Sciences · 99
2002 · Suzanne E. Beck, Beth L. Laube, et al. · Molecular Therapy · 91
2005 · Isabel Virella‐Lowell, Benjamin Zusman, et al. · The Journal of Gene Medicine · 71
2009 · Zejing Wang, Rainer Storb, et al. · Molecular Therapy · 47
2004 · Cathryn Mah, Thomas J Fraites, et al. · Molecular Therapy · 30
2012 · Peter Ward, Christopher E. Walsh · Virology · 27
2009 · Jaehyung Kim, Sung Jin Kim, et al. · Biochemical and Biophysical Research Communications · 27
2005 · Shiue-Cheng Tang, Athanassios Sambanis, et al. · Biochemical and Biophysical Research Communications · 23
2023 · José Escandell, Filipa Moura, et al. · Biotechnology and Bioengineering · 21
2020 · Marshall S. Goodwin, Cara L. Croft, et al. · Molecular Neurodegeneration · 20
2024 · Aurélien Leray, Pierre-Alban Lalys, et al. · Biomedicine & Pharmacotherapy · 18
2019 · Mariana S. Dias, Victor G. Araujo, et al. · Gene Therapy · 18
2018 · Qi Lu, Tushar H. Ganjawala, et al. · Investigative Ophthalmology & Visual Science · 16
2023 · Żaneta Słyk, Robert Wrzesień, et al. · Biomedicine & Pharmacotherapy · 14
2021 · Pranav Pandharipande, Tuhin Bhowmik, et al. · Journal of Pharmaceutical Sciences · 11
Works count: 108
Citation count: 1,505
Year
Topic
Type